AG Singal, El-Serag H, Hepatocellular Carcinoma From Epidemiology to Prevention: Translating Knowledge into Practice. Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association. 2015 Nov. 13. 12. 2140-51.
PubMed PMID: 26284591; PubMed Central ID: PMC4618036; Publication Status: Published

Coarfa C, Fu L, Lee C, Sreekumar A, Putluri N, Moore DD, Voicu H, Kettner NM, Katchy CA, Finegold MJ, Circadian Homeostasis of Liver Metabolism Suppresses Hepatocarcinogenesis.. Cancer cell. 2016 Dec 12. 30. 6. 909-924.
PubMed PMID: 27889186; PubMed Central ID: PMC5695235; Publication Status: Published

N Tayob, Z Feng, K Do, F Stingo, A Lok, A Bayesian screening approach for hepatocellular carcinoma using multiple longitudinal biomarkers.. Biometrics. 2017 May 8.
PubMed PMID: 28482112; PubMed Central ID: PMC5677596; Publication Status: Published

Borowiak M, Hu J, Parsons DW, Bissig-Choisat B, Muzny D, Yang D, Vasudevan SA, Hampton OA, Legras XD, Thompson PA, Chen LL, Finegold M, Zorman B, Sumazin P, López-Terrada D, Gaber MW, Huang YH, Pautler RG, Kettlun-Leyton C, Bissig KD, Goss JA, Shi Y, Doddapaneni HV, Barzi M, Prakash MM, Hicks MJ, Lu Y, Mills GB, Amin MD, Novel patient-derived xenograft and cell line models for therapeutic testing of pediatric liver cancer.. Journal of hepatology. 2016 Aug. 65. 2. 325-33.
PubMed PMID: 27117591; PubMed Central ID: PMC5668139; Publication Status: Published

Singal AG, Rich NE, Parikh ND, Marrero JA, Tzartzeva K, Yopp A, Waljee AK, Obi J, Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis.. Gastroenterology. 2018 May. 154. 6. 1706-1718.e1.
PubMed PMID: 29425931; PubMed Central ID: PMC5927818; Publication Status: Published

Lok AS, Feng Z, Shen W, Ning J, Yuan Y, Model-free scoring system for risk prediction with application to hepatocellular carcinoma study.. Biometrics. 2018 Mar. 74. 1. 239-248.
PubMed PMID: 28742219; PubMed Central ID: PMC5785588; Publication Status: Published

Lok AS, Tayob N, Feng Z, Do KA, Improved Detection of Hepatocellular Carcinoma by Using a Longitudinal Alpha-Fetoprotein Screening Algorithm. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2016 Mar. 14. 3. 469-475.e2.
PubMed PMID: 26260109; PubMed Central ID: PMC4744807; Publication Status: Published

Desiderio R, Thrift AP, Asch SM, Kramer JR, Mapakshi S, Chu J, Chayanupatkul M, El-Serag HB, Kanwal F, Li L, Richardson PA, Natarajan Y, Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease.. Gastroenterology. 2018 Dec. 155. 6. 1828-1837.e2.
PubMed PMID: 30144434; PubMed Central ID: PMC6279617; Publication Status: Published

Pankowicz FP, Moore DD, Elsea SH, Wooton-Kee CR, Marini JC, Kim KH, Bissig-Choisat B, Lagor WR, Legras X, Barzi M, Martins CS, Bissig KD, Rapid Disruption of Genes Specifically in Livers of Mice Using Multiplex CRISPR/Cas9 Editing. Gastroenterology. 2018 Dec. 155. 6. 1967-1970.e6.
PubMed PMID: 30170115; PubMed Central ID: PMC6420307; Publication Status: Published

Ohsfeldt RL, Kum HC, Choi DT, Singal AG, Park S, Shen Y, Parikh ND, Hepatocellular Carcinoma Screening Is Associated With Increased Survival of Patients With Cirrhosis. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2019 Apr. 17. 5. 976-987.e4.
PubMed PMID: 30616961; PubMed Central ID: PMC6431264; Publication Status: Published

Halm EA, Singal AG, Mejias C, Santini NO, Tiro JA, Waljee AK, Pechero W, Murphy CC, Marrero JA, Fullington H, McCallister K, Mailed Outreach Invitations Significantly Improve HCC Surveillance Rates in Patients With Cirrhosis: A Randomized Clinical Trial.. Hepatology (Baltimore, Md.). 2019 Jan. 69. 1. 121-130.
PubMed PMID: 30070379; PubMed Central ID: PMC6324997; Publication Status: Published

Loo N, Feng Z, Ning J, Marrero JA, Khaderi S, El-Serag HB, Beretta L, Singal AG, Kanwal F, Design of the Texas Hepatocellular Carcinoma Consortium Cohort Study.. The American journal of gastroenterology. 2019 Mar. 114. 3. 530-532.
PubMed PMID: 30699099; PubMed Central ID: Publication Status: Published

El-Serag HB, Kramer JR, Dai J, Asch SM, Li L, Yu X, Natarajan Y, Kanwal F, Effect of Metabolic Traits on the Risk of Cirrhosis and Hepatocellular Cancer in Nonalcoholic Fatty Liver Disease.. Hepatology (Baltimore, Md.). 2020 Mar. 71. 3. 808-819.
PubMed PMID: 31675427; PubMed Central ID: Publication Status: Published

Marrero JA, Texas Consortium., Feng Z, Kanwal F, El-Serag HB, Singal AG, Khaderi S, Risk Factors for Cirrhosis in Contemporary Hepatology Practices-Findings From the Texas Hepatocellular Carcinoma Consortium Cohort.. Gastroenterology. 2020 Mar 29.
PubMed PMID: 32234536; PubMed Central ID: Publication Status: Published

Ning J, Feng Z, Li R, Li W, Semiparametric isotonic regression analysis for risk assessment under nested case-control and case-cohort designs. Statistical methods in medical research. 2019 Dec 22. 962280219893389.
PubMed PMID: 31868119; PubMed Central ID: Publication Status: In Press

Circulating Osteopontin and Prediction of Hepatocellular Carcinoma Development in a Large European Population. Cancer Prevention Research. 2016 Jun 23.
PubMed PMID: 27339170; PubMed Central ID: PMC5010922; Publication Status: Published


Media Component

The Texas Hepatocellular Carcinoma Consortium is made possible by grant RP150587 from the Cancer Prevention and Research Institute of Texas, PI: Hashem B. El-Serag.